ATE429240T1 - Bukkales verabreichungssystem für proteinhaltige medikamente - Google Patents

Bukkales verabreichungssystem für proteinhaltige medikamente

Info

Publication number
ATE429240T1
ATE429240T1 AT00907063T AT00907063T ATE429240T1 AT E429240 T1 ATE429240 T1 AT E429240T1 AT 00907063 T AT00907063 T AT 00907063T AT 00907063 T AT00907063 T AT 00907063T AT E429240 T1 ATE429240 T1 AT E429240T1
Authority
AT
Austria
Prior art keywords
delivery system
protein containing
buccal delivery
formulation
containing medications
Prior art date
Application number
AT00907063T
Other languages
English (en)
Inventor
David Mundschenk
Original Assignee
Esperanza Peptide Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Esperanza Peptide Ltd filed Critical Esperanza Peptide Ltd
Application granted granted Critical
Publication of ATE429240T1 publication Critical patent/ATE429240T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nutrition Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT00907063T 1999-01-29 2000-01-28 Bukkales verabreichungssystem für proteinhaltige medikamente ATE429240T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US24045599A 1999-01-29 1999-01-29
PCT/US2000/002210 WO2000044393A2 (en) 1999-01-29 2000-01-28 Buccal delivery system for proteinaceous medicaments

Publications (1)

Publication Number Publication Date
ATE429240T1 true ATE429240T1 (de) 2009-05-15

Family

ID=22906597

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00907063T ATE429240T1 (de) 1999-01-29 2000-01-28 Bukkales verabreichungssystem für proteinhaltige medikamente

Country Status (7)

Country Link
US (1) US20070014735A1 (de)
EP (1) EP1146890B1 (de)
AT (1) ATE429240T1 (de)
AU (1) AU2862600A (de)
CA (1) CA2361262A1 (de)
DE (1) DE60042057D1 (de)
WO (1) WO2000044393A2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0501037B8 (pt) * 2005-03-18 2021-07-27 Fund De Amparo A Pesquisa Do Estado De Sao Paulo uso de crotamina e composição
AT506216B1 (de) 2008-02-13 2009-07-15 Peter Dr Hernuss Zusammensetzung zur aufnahme über mukoses gewebe
US20100291160A1 (en) * 2009-05-13 2010-11-18 Carver David R Pharmaceutical system for trans-membrane delivery
CN116270972A (zh) * 2022-01-24 2023-06-23 中国人民解放军总医院第一医学中心 一种多肽类镇痛药物及其制备方法和其应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2127689B (en) * 1982-10-05 1986-07-09 Sandoz Ltd Calcitonin inhalation compositions
ES2061688T3 (es) * 1987-11-13 1994-12-16 Smithkline Beecham Farma Composiciones farmaceuticas que comprenden una calcitonina y un glicirricinato como mejorador de la absorcion.
DK0550031T3 (da) * 1991-12-31 1996-08-26 Solvay Medicinsk aerosolformulering
CA2253937A1 (en) * 1996-05-10 1997-11-20 Phylomed Corporation Methods for oxidizing disulfide bonds using ozone

Also Published As

Publication number Publication date
DE60042057D1 (de) 2009-06-04
US20070014735A1 (en) 2007-01-18
WO2000044393A2 (en) 2000-08-03
EP1146890B1 (de) 2009-04-22
WO2000044393A3 (en) 2000-12-14
CA2361262A1 (en) 2000-08-03
AU2862600A (en) 2000-08-18
EP1146890A2 (de) 2001-10-24

Similar Documents

Publication Publication Date Title
DE60019598D1 (de) Verbindungen zur behandlung von sexuellen funktionsstörungen
CA2214323A1 (en) Compounds and compositions for delivering active agents
WO1999053910A8 (en) Folic acid-containing pharmaceutical compositions, and related methods and delivery systems
HUP0004310A3 (en) Cyclic amino acids, and derivatives thereof and pharmaceutical compositions comprising the said compounds as active agents
EP0528312A3 (de) Zyklische Peptide und ihre Verwendung
CY1108547T1 (el) Αναλογα σωματοστατινης
EP1077070A3 (de) Orale Darreichungsform
ATE332922T1 (de) Antimikrobiell wirkendes peptid
AU4363199A (en) Use of hmg proteins for the preparation of medicaments having cytotoxic activity
AU7134898A (en) Biodegradable microparticles for the sustained delivery of therapeutic drugs
BR9812553A (pt) Formulação medicamentosa com liberação de substância ativa controlada
BR0214363A (pt) Anticorpo, uso de um anticorpo, medicamento, método de fabricação de um medicamento e pacote farmacêutico para o tratamento de infecção
ATE429240T1 (de) Bukkales verabreichungssystem für proteinhaltige medikamente
HU0003836D0 (en) Dosing regimens for lasofoxifene
MXPA05010390A (es) Composiciones y metodos para la liberacion de timosina beta 4, analogos, isoformas y otros derivados.
SE9901773D0 (sv) Förebyggande av karies i tänderna
MXPA01003340A (es) Composiciones farmaceuticas en base a alfa-ciclodextrina para la administracion por via oral de analogos de lh-rh.
GB9910375D0 (en) Vaccine composition
EP1593384A3 (de) Verbindungen zur Behandlung von sexuellen Funktionsstörungen
EP1602665A4 (de) Physiologisch aktive peptide und medikamente, die diese enthalten
IL162857A0 (en) Oral vaccination
NZ509284A (en) Tumour antigen peptide derived from SART-that binds to HLA-A24 antigen thereby facilitating recognition by a T call
TH26711A (th) " สิ่งที่คล้ายกันของปัจจัยหลั่งฮอโมนของการเจริญเติบโต "
CA2315241A1 (en) Protein rim2
UA83996C2 (ru) Фармацевтическая гелевая композиция пептидов, способ ее получения, набор для ее получения и ее применение

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties